Mylan To Enter Japanese Market , CEO Says
This article was originally published in PharmAsia News
Executive Summary
American generic drug giant Mylan plans to expand into the Japanese market, Mylan CEO Robert J Coury announced during a press briefing in Tokyo. Coury said that Mylan will take Japanese market needs into consideration and start by supplying drug materials to Japanese pharmaceutical companies. Regarding a possible buyout of a Japanese generic drug maker, Coury commented that Mylan considers it as one option, but that an acquisition is not the only way to capture market share. Ranked as the world's number three generic drug maker, Mylan has commercial operations in 92 countries and sales of $4.2 billion in 2007. (Click here for more - Japanese language